AAAAAA

   
Results: 1-16 |
Results: 16
Inactivation of the p16(INK4A) gene by methylation is not a frequent eventin sporadic ovarian carcinoma
Authors: Brown, I Milner, BJ Rooney, PH Haites, NE
Citation: I. Brown et al., Inactivation of the p16(INK4A) gene by methylation is not a frequent eventin sporadic ovarian carcinoma, ONCOL REP, 8(6), 2001, pp. 1359-1362
Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?
Authors: Gates, LJ Benjamin, N Haites, NE MacConnachie, AA McLay, JS
Citation: Lj. Gates et al., Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?, J HUM HYPER, 15(3), 2001, pp. 173-176
Breast cancer in two sisters with Friedreich's ataxia
Authors: Kidd, A Coleman, R Whiteford, M Barron, LH Simpson, SA Haites, NE
Citation: A. Kidd et al., Breast cancer in two sisters with Friedreich's ataxia, EUR J SUR O, 27(5), 2001, pp. 512-514
Cytochrome P450CYP1B1 over-expression in primary and metastatic ovarian cancer
Authors: McFadyen, MCE Cruickshank, ME Miller, ID McLeod, HL Melvin, WT Haites, NE Parkin, D Murray, GI
Citation: Mce. Mcfadyen et al., Cytochrome P450CYP1B1 over-expression in primary and metastatic ovarian cancer, BR J CANC, 85(2), 2001, pp. 242-246
Immunohistochemical detection of a germline BRCA1 mutation in a breast andovarian cancer family
Authors: Schofield, AC Payne, S Ross, VG Miller, ID Heys, SD Haites, NE
Citation: Ac. Schofield et al., Immunohistochemical detection of a germline BRCA1 mutation in a breast andovarian cancer family, BREAST, 9(5), 2000, pp. 286-291
CYP3A4 promoter variant in Saudi, Ghanaian and Scottish Caucasian populations
Authors: Tayeb, MT Clark, C Ameyaw, MM Haites, NE Evans, DAP Tariq, M Mobarek, A Ofori-Adjei, D McLeod, HL
Citation: Mt. Tayeb et al., CYP3A4 promoter variant in Saudi, Ghanaian and Scottish Caucasian populations, PHARMACOGEN, 10(8), 2000, pp. 753-756
A survey of the current clinical facilities for the management of familialcancer in Europe
Authors: Hodgson, SV Haites, NE Caligo, M Chang-Claude, J Eccles, D Evans, G Moller, P Morrison, P Steel, CM Stoppa-Lyonnet, D Vasen, H
Citation: Sv. Hodgson et al., A survey of the current clinical facilities for the management of familialcancer in Europe, J MED GENET, 37(8), 2000, pp. 605-607
Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies
Authors: Stronach, EA Clark, C Bell, C Lofgren, A McKay, NG Timmerman, V Van Broeckhoven, C Haites, NE
Citation: Ea. Stronach et al., Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies, J PERIPH N, 4(2), 1999, pp. 117-122
Asthma, wheezy bronchitis, and atopy across two generations
Authors: Christie, GL Helms, PJ Godden, DJ Ross, SJ Friend, JAR Legge, JS Haites, NE Douglas, JG
Citation: Gl. Christie et al., Asthma, wheezy bronchitis, and atopy across two generations, AM J R CRIT, 159(1), 1999, pp. 125-129
A protective role for common p21(WAF1/Cip1) polymorphisms in human ovariancancer
Authors: Milner, BJ Brown, I Gabra, H Kitchener, HC Parkin, DE Haites, NE
Citation: Bj. Milner et al., A protective role for common p21(WAF1/Cip1) polymorphisms in human ovariancancer, INT J ONCOL, 15(1), 1999, pp. 117-119
Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Stoppa-Lyonnet, D Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics, DIS MARKER, 15(1-3), 1999, pp. 47-47
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
Authors: Stoppa-Lyonnet, D Caligo, M Eccles, D Evans, DGR Haites, NE Hodgson, NS Moller, P Morrison, PJ Steel, CM Vasen, HFA Chang-Claude, J
Citation: D. Stoppa-lyonnet et al., Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?, DIS MARKER, 15(1-3), 1999, pp. 67-68
Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe
Authors: Morrison, PJ Steel, CM Vasen, HFA Eccles, D Evans, DGR Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Olah, E Haites, NE Nevin, NC
Citation: Pj. Morrison et al., Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe, DIS MARKER, 15(1-3), 1999, pp. 159-165
Comparative genomic hybridization and chromosomal instability in solid tumours
Authors: Rooney, PH Murray, GI Stevenson, DAJ Haites, NE Cassidy, J McLeod, HL
Citation: Ph. Rooney et al., Comparative genomic hybridization and chromosomal instability in solid tumours, BR J CANC, 80(5-6), 1999, pp. 862-873
Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Lyonet, DS Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics, EUR J CANC, 34(12), 1998, pp. 1922-1926
Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism
Authors: MacConnachie, AA Kelly, KF McNamara, A Loughlin, S Gates, LJ Inglis, GC Jamieson, A Connell, JMC Haites, NE
Citation: Aa. Macconnachie et al., Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism, J CLIN END, 83(12), 1998, pp. 4328-4331
Risultati: 1-16 |